Ventricular Abnormalities

An illustration shows where ventricular arrhythmias and abnormalities occur in the heart chamber.

What are Ventricular Abnormalities?

Ventricular abnormalities are electrical signals that originate from the ventricles (bottom pumping chambers of the heart). Ventricular abnormalities can occur in individuals who do not have DCM. Ventricular abnormalities often indicate the presence of heart muscle disease. For example, heart muscle, which has been damaged by a heart attack and has formed scar tissue, can develop ventricular abnormalities. In DCM, the heart muscle is diseased and the ventricles have the most heart muscle, compared to other heart structures (like the atria). There are three main categories of ventricular abnormalities that commonly occur in DCM and can be very significant: Premature Ventricular Complexes, Ventricular Tachycardia, and Ventricular Fibrillation.

Premature Ventricular Complexes

Premature Ventricular Complexes (PVCs) are electrical signals that originate from the ventricles and occur even when the normal electrical signals are present. PVCs can be seen on an ECG as extra complexes that occur earlier than the next normal complex. They are followed by a compensatory pause, which allows the normal electrical signals to resume their normal rate and pattern. They can cause the heart to contract (a heartbeat), but often do not cause the heart to contract or the contraction is weaker than usual. PVCs can occur infrequently or frequently. If they occur frequently in a person with DCM, they can further impair the heart contraction and symptoms of heart failure can worsen.

An image shows premature ventricular complexes on an ECG.
Credit: litfl.com

Frequently occurring PVCs can occur every third complex, called trigeminy, as shown in the above ECG. PVCs that occur every other complex are called bigeminy and those that occur every fourth complex are called quadgeminy. If there is a concern that a person with DCM is having a lot of these PVCs, they can wear a special heart monitor that tracks the heart rate and rhythm.

If the monitor confirms a high number of PVCs, therapies to suppress them will then be considered, including specific drugs and ablation therapy. Beta blockers are the best drugs to decrease or suppress PVCs in DCM. However, when beta blockers are not effective, other drugs, or ablation therapy (the use of catheters and forms of energy to destroy tissue from where the PVCs originate), can be considered. It is appropriate to consult with cardiologists who specialize in heart rhythm abnormalities (electrophysiologists).

Ventricular Tachycardia

Ventricular Tachycardia (VT) is a “run” of ventricular complexes. The minimum length of a run is three complexes in a row at a minimal rate of 100/minute. VT can also be sustained; sustained VT lasts at least 30 seconds at a minimal rate of 100/minute.

There is a broad spectrum of how VT is tolerated by a person. VT can occur without any symptoms. However, even if it occurs without symptoms, VT can deteriorate into Ventricular Fibrillation (see below), making it a life-threatening heart rhythm. Symptoms can be mild (palpitations, light-headedness) to more severe (chest pain, shortness of breath, feeling faint or a feeling of doom), to actually losing consciousness (syncope) and possibly death. VT can also cause low blood pressure because the heart does not contract normally and pump blood effectively.

Since all individuals with DCM and an ejection fraction of 30 to 35%, or less, are at high risk of developing VT, they meet criteria for an implantable cardiac defibrillator (ICD), which is implanted like a pacemaker. It monitors for VT and Ventricular Fibrillation (see below) and, if detected, delivers therapies to stop the VT and return the heart to a normal rhythm.

One such therapy is to deliver high rates of paced beats to stop the VT. The other therapy is to deliver shocks to stop the VT. If a person is having a lot of VT and is at risk of getting many shocks to treat it, specific drugs are used in addition to the ICD to either prevent the VT or slow its rate. One of the most commonly used drugs is amiodarone.

Sometimes VT is caused by scar tissue in the ventricles. This type of VT can often be treated by ablation (the use of catheters and forms of energy to destroy tissue from where the VT originates). It is appropriate to consult with cardiologists who specialize in heart rhythm abnormalities and these procedures (electrophysiologists).

This ECG shows a short run of VT.
An image of an ECG showing a short run of ventricular tachycardia.

This ECG shows a normal rhythm at the start with a single PVC (arrow) and then the development of VT.
An image of an ECG showing a normal rhythm at the start with a single premature ventricular complexe and then the development of ventricular tachycardia.

Ventricular Fibrillation

Ventricular Fibrillation (VF) is always a life-threatening rhythm because the heart is unable to contract and pump blood. VF will cause death if it is not terminated and is the most common cause for sudden death, or sudden cardiac death (SCD). These are terms used to describe loss of consciousness accompanied by loss of heart beats, blood pressure, and breathing (cardiac arrest).

A person in cardiac arrest must undergo successful cardiopulmonary resuscitation (CPR) to survive. One of the most important interventions during CPR, in addition to chest compressions, is to deliver an electric shock over the heart, which is the best therapy to stop the VF. Automated External Defibrillators (AEDs) located in public areas are used for this purpose.

A person with DCM and an ejection fraction of 30 to 35%, or less, is at high risk of SCD and meets the criteria for the implantation of an ICD to treat the VF. When an ICD detects VF, it will immediately give an electric shock to stop the VF. ICDs have been shown to increase life expectancy in those with DCM and ejection fractions of 30 to 35% or less.

An image of an ECG showing ventricular fibrillation.

Click to Explore:

CONDUCTION ABNORMALITIES
ATRIAL ABNORMALITIES
DCM AND COMMON ARRHYTHMIAS

SYMPTOMS
STAGES
CAUSES
GENETICS

Personal Stories and Perspectives

Hear from a

Medical Expert

Share with us how the DCM Foundation can be a resource for you.

We are assembling a list of DCM patients, family members, health care professionals and champions who support our mission to become the leading resource for DCM education, research and advocacy.

Providing your contact information for this list means you may receive occasional updates from us, as well as requests for feedback on the foundation and our website. Your comments are welcome and appreciated.